---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-25-017219"
form_type: "8-K"
ticker: "MDCX"
cik: "0001997296"
company_name: "Medicus Pharma Ltd."
filed_at: "2025-12-08T23:59:59+00:00"
generated_at: "2026-05-16T14:07:08.179806+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Medicus Pharma enters $5.1M warrant inducement; issues new warrants for 4M shares

## Summary
- Gross proceeds ~$5.1M from exercise of 2,680,000 existing warrants at amended price of $1.92/share.
- Issued new unregistered Series C/D warrants to purchase 4,020,000 common shares at $2.00, expiring June 5, 2031.
- Company agreed to file resale registration statement for new warrant shares within 60 days of agreement.
- Also reported SEPA sales of 680,893 common shares for ~$1.5M from Oct 28 to Dec 4, 2025.
- Maxim Group LLC acted as exclusive financial advisor; 6.0% cash fee on gross proceeds.

## SEC filing metadata
- accession: 0001062993-25-017219
- form_type: 8-K
- ticker: MDCX
- cik: 0001997296
- company_name: Medicus Pharma Ltd.
- filed_at: 2025-12-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1997296/000106299325017219/0001062993-25-017219-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1997296/000106299325017219/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-25-017219
- JSON: https://secwatch.observer/filing/0001062993-25-017219.json
- Plain text: https://secwatch.observer/filing/0001062993-25-017219.txt

## Key facts
- Equity Issuances
  Medicus Pharma Ltd. issued 680,893 of common stock to YA II PN, Ltd. (Yorkville) for $1,500,905 aggregate.
  - Security: common stock
  - Shares: 680,893
  - Purchaser: YA II PN, Ltd. (Yorkville)
  - Consideration: $1,500,905 aggregate
  source text: the Company completed sales of its common shares (the "Common Shares") to Yorkville (collectively, the "SEPA Advances") as disclosed in the table below: Date of Sale Number of Common Shares Price per share Approximate Aggregate Consideration October 28, 2025 250,000 $2.3760 $594,000 November 5, 2025 83,333 $2.2691 $189,091 November 5, 2025 14,659 $2.1825 $31,993 November 14, 2025 83,375 $2.2374 $186,543 November 14, 2025 4,526 $2.231 $10,098 November 20, 2025 33,333 $2.3423 $78,076 November 20, 2025 31,667 $2.2795 $72,185 November 28, 2025 66,667 $1.9462 $129,747 November 28, 2025 33,333 $1.9400 $64,666 December 4, 2025 33,333 $1.9587 $65,289 December 4, 2025 46,667 $1.6975 $79,217 Total 680,893 - $1,500,905
  evidence_url: https://www.sec.gov/Archives/edgar/data/1997296/000106299325017219/0001062993-25-017219-index.htm
- Equity Issuances
  Medicus Pharma Ltd. issued up to 4,020,000 Common Shares of warrant to accredited and institutional holder for amended exercise price of $1.92 per Common Share.
  - Security: warrant
  - Shares: up to 4,020,000 Common Shares
  - Purchaser: accredited and institutional holder
  - Consideration: amended exercise price of $1.92 per Common Share
  source text: (the "Holder") to exercise existing warrants to purchase up to 2,680,000 of the Company's common shares ("Common Shares") issued on July 14, 2025 at an amended exercise price of $1.92 per Common Share (the "Existing Warrants"). Pursuant to the Agreement, the Holder, upon exercise, will receive new unregistered warrants (the "New Warrants") to purchase up to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1997296/000106299325017219/0001062993-25-017219-index.htm
- Material Agreements
  Medicus Pharma Ltd. entered into Warrant Inducement Agreement with a certain accredited and institutional holder valued at approximately $5.1 million (effective 2025-12-05).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a certain accredited and institutional holder
  - Value: approximately $5.1 million
  - Effective: 2025-12-05
  source text: On December 5, 2025, Medicus Pharma Ltd. (the "Company") entered into an inducement offer (the "Agreement") with a certain accredited and institutional holder (the "Holder") to exercise existing warrants to purchase up to 2,680,000 of the Company's common shares ("Common Shares") issued on July 14, 2025 at an amended exercise price of $1.92 per Common Share (the "Existing Warrants").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1997296/000106299325017219/0001062993-25-017219-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.